These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 16414341

  • 1. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy?
    Greendale GA, Gold EB.
    Am J Med; 2005 Dec 19; 118 Suppl 12B():148-54. PubMed ID: 16414341
    [Abstract] [Full Text] [Related]

  • 2. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society.
    North American Menopause Society.
    Menopause; 2004 Dec 19; 11(1):11-33. PubMed ID: 14716179
    [Abstract] [Full Text] [Related]

  • 3. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
    Svartberg J, von Mühlen D, Kritz-Silverstein D, Barrett-Connor E.
    Menopause; 2009 Dec 19; 16(5):888-91. PubMed ID: 19421076
    [Abstract] [Full Text] [Related]

  • 4. Standard and low-dose hormone therapy for postmenopausal women--focus on the breast.
    Wang PH, Horng HC, Cheng MH, Chao HT, Chao KC.
    Taiwan J Obstet Gynecol; 2007 Jun 19; 46(2):127-34. PubMed ID: 17638620
    [Abstract] [Full Text] [Related]

  • 5. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women's Health Across the Nation.
    Gold EB, Block G, Crawford S, Lachance L, FitzGerald G, Miracle H, Sherman S.
    Am J Epidemiol; 2004 Jun 15; 159(12):1189-99. PubMed ID: 15191936
    [Abstract] [Full Text] [Related]

  • 6. Duration of vasomotor symptoms in middle-aged women: a longitudinal study.
    Col NF, Guthrie JR, Politi M, Dennerstein L.
    Menopause; 2009 Jun 15; 16(3):453-7. PubMed ID: 19188852
    [Abstract] [Full Text] [Related]

  • 7. Factors associated with reporting classic menopausal symptoms differ.
    Duffy OK, Iversen L, Hannaford PC.
    Climacteric; 2013 Apr 15; 16(2):240-51. PubMed ID: 22992029
    [Abstract] [Full Text] [Related]

  • 8. The relationship between exercise, Body Mass Index and menopausal symptoms in midlife Australian women.
    Mirzaiinjmabadi K, Anderson D, Barnes M.
    Int J Nurs Pract; 2006 Feb 15; 12(1):28-34. PubMed ID: 16403194
    [Abstract] [Full Text] [Related]

  • 9. Exercise participation, body mass index, and health-related quality of life in women of menopausal age.
    Daley A, Macarthur C, Stokes-Lampard H, McManus R, Wilson S, Mutrie N.
    Br J Gen Pract; 2007 Feb 15; 57(535):130-5. PubMed ID: 17266830
    [Abstract] [Full Text] [Related]

  • 10. Effect of physical activity on menopausal symptoms among urban women.
    Nelson DB, Sammel MD, Freeman EW, Lin H, Gracia CR, Schmitz KH.
    Med Sci Sports Exerc; 2008 Jan 15; 40(1):50-8. PubMed ID: 18091021
    [Abstract] [Full Text] [Related]

  • 11. Vasomotor symptoms usually reappear after cessation of postmenopausal hormone therapy: a Swedish population-based study.
    Lindh-Astrand L, Brynhildsen J, Hoffman M, Hammar M.
    Menopause; 2009 Jan 15; 16(6):1213-7. PubMed ID: 19455070
    [Abstract] [Full Text] [Related]

  • 12. The menopausal hot flush--anything new?
    Sturdee DW.
    Maturitas; 2008 May 20; 60(1):42-9. PubMed ID: 18384981
    [Abstract] [Full Text] [Related]

  • 13. Adiposity and reporting of vasomotor symptoms among midlife women: the study of women's health across the nation.
    Thurston RC, Sowers MR, Chang Y, Sternfeld B, Gold EB, Johnston JM, Matthews KA.
    Am J Epidemiol; 2008 Jan 01; 167(1):78-85. PubMed ID: 17881385
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A universal menopausal syndrome?
    Avis NE, Brockwell S, Colvin A.
    Am J Med; 2005 Dec 19; 118 Suppl 12B():37-46. PubMed ID: 16414325
    [Abstract] [Full Text] [Related]

  • 16. The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
    Osborne CR, Duncan A, Sedlacek S, Paul D, Holmes F, Vukelja S, Kasper M, Wilks S, Schneider A, McGee R, Meyer WG, O'Shaughnessy JA.
    Breast Cancer Res Treat; 2009 Aug 19; 116(3):521-7. PubMed ID: 19139988
    [Abstract] [Full Text] [Related]

  • 17. Treatment of vasomotor symptoms in the menopausal transition and postmenopausally: psychiatric comorbidity.
    Alexander JL, Burger H, Dennerstein L, Woods NF, Davis SR, Kotz K, Van Winkle J, Richardson G, Ratka A, Kessel B.
    Expert Rev Neurother; 2007 Nov 19; 7(11 Suppl):S115-37. PubMed ID: 18039061
    [Abstract] [Full Text] [Related]

  • 18. Epidemiology of risk factors and symptoms associated with menopause in Spanish women.
    Pérez JA, Garcia FC, Palacios S, Pérez M.
    Maturitas; 2009 Jan 20; 62(1):30-6. PubMed ID: 19010615
    [Abstract] [Full Text] [Related]

  • 19. Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life.
    Williams RE, Levine KB, Kalilani L, Lewis J, Clark RV.
    Maturitas; 2009 Feb 20; 62(2):153-9. PubMed ID: 19157732
    [Abstract] [Full Text] [Related]

  • 20. Lifestyle characteristics and hypertension in the middle-aged population of Kraków.
    Pajak A, Kawalec E.
    Blood Press Suppl; 2005 Dec 20; 2():17-21. PubMed ID: 16429637
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.